Leuprolide
DB00007
Approved Indication
For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty
1
Targets
0
Resistance Mutations
3
References
3D Structure
No structure available
No co-crystal structure available
Protein Targets
Mechanism of Action
Leuprolide binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion.
Details
DrugBank ID
DB00007 ↗
Approval Date
1989-01-26
Molecular Weight
— g/mol
Drug Class
Other
ATC Codes
L02AE02
Synonyms
Leuprorelin, Leuprorelina, Leuproreline
ChEMBL
CHEMBL1201199 ↗
Drug References (DrugBank)